I-PEN

3 stories · following the connections

Business

I-MED Pharma’s I-PEN® Receives Regulatory Approval from INVIMA in Colombia and ANMAT in Argentina

By Nasdaq OMXApr 3, 2018, 6:30 PM UTC

Business

I-MED Pharma's I-PEN® Does Not Infringe the TearLab Patent

By Nasdaq OMXFeb 20, 2018, 8:44 PM UTC

Business

I-MED Pharma Wins Patent Case Against TearLab

By Nasdaq OMXFeb 13, 2018, 8:55 PM UTC